Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6016574 | European Journal of Paediatric Neurology | 2016 | 7 Pages |
Abstract
Our study does not support a clear benefit of systematic MRI screening in NF1 children under six years old. Systematic neuroimaging in our study did not influence therapeutic management. Although OPG diagnosis was made early, treatment with chemotherapy did not improve the final visual outcome. If MRI remains the best tool for the diagnosis of cerebral and spinal pathologies in the NF1 population, our current study questions the usefulness of systematic MRI screening for OPG diagnosis. Conversely, this study suggests that the indication of neuroimaging should be dictated by the results of annual clinical and ophthalmological assessments.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Gaelle Blanchard, Marie-Pierre Lafforgue, Laurence Lion-François, Isabelle Kemlin, Diana Rodriguez, Pierre Castelnau, Maryline Carneiro, Pierre Meyer, François Rivier, Sébastien Barbarot, Yves Chaix, NF France network NF France network,